Key result
Three years after renal denervation, patients with resistant hypertension experienced a persistent decrease in blood pressure by an average of 17/10 mmHg compared to baseline, regardless of sex.
Why the study?
The study was conducted to evaluate the 3-year outcomes of renal denervation regarding blood pressure, target organ damage, and cytokine levels in resistant hypertension, taking into account sex characteristics.
Does renal denervation reduce blood pressure and target organ damage in patients with resistant hypertension?
Observational (n=42)
No
Does renal denervation reduce blood pressure and target organ damage in patients with resistant hypertension?
Renal denervation provides sustained blood pressure reduction and target organ protection over 3 years in patients with resistant hypertension, with sex-specific differences in BP variability and LV mass regression.
Answers are grounded in this paper and cite their sources.
Supports sustained BP reduction after renal denervation; leaves open confirmation in randomized trials.
Aim . To study the long-term outcomes of renal denervation (RDN) within 3-year follow-up with an assessment of blood pressure (BP) changes, the severity of target organ damage and the levels of pro- and anti-inflammatory cytokines in patients with resistant hypertension (RH), taking into account sex characteristics. Material and methods . A total of 42 patients with RH were examined at baseline, 1, 2, and 3 years after RDN on the background of antihypertensive therapy. Twenty-four-hour BP monitoring, echocardiography, assessment of creatinine level and estimated glomerular filtration rate (eGFR), as well as determination of some cytokines (interleukin (IL)-1β, 6, 10, tumor necrosis factor-α) were performed. Results . There was a persistent BP decrease in men and women for three years compared with the initial level by an average of 17 [4; 31]/10 [0; 18] mm Hg (p<0,05). Decrease in BP variability from 17,9±5,1 to 15,2±3,6 mm Hg was observed mainly by means of women, while the decrease in left ventricular mass from 250,4±64,0 to 229,3±61,9 g was mainly by means of men. Creatinine level was unchanged, while eGFR decreased from 78,8±16,1 to 74,5±20,3 ml/ min/1,73 m 2 over 3 years; the mean eGFR decline was 1,4 ml/min/1,73 m 2 in year. All studied cytokines tended to decrease regardless of sex: tumor necrosis factor-α — from 2,1 [1,2; 77] to 2,1 [1,7; 2,6] pg/ml (p=0,022); IL-1β — from 2,2 [1,5; 2,4] to 1,6 [1,1; 1,5] pg/ml (p=0,034); IL-6 — from 3,8 [1,6; 4,9] to 2,8 [1,8; 3,0] pg/ml (p>0,05), IL-10 — from 5,8 [3,2; 8,2] to 2,8 [2,6; 2,9] pg/ml (p=0,000), correlating with IL-6 dynamics. Conclusion . Three years after RDN, there is a persistent decrease in mean 24-hour BP, regardless of sex. In women, a more pronounced BP variability decrease is observed, while in men — regression of left ventricular mass. There is no significant decrease in eGFR in the long-term period. The decrease in proinflammatory cytokines maintains, and in some cases becomes more pronounced within three years after RDN.
No takes yet. Share an insight, caveat, or question.
Zyubanova et al. (2021) conducted an observational in Resistant hypertension (n=42). Renal denervation vs. Baseline was evaluated on Decrease in mean 24-hour systolic blood pressure (17 mmHg reduction, p=<0.05). Three years after renal denervation, patients with resistant hypertension experienced a persistent decrease in blood pressure by an average of 17/10 mmHg compared to baseline, regardless of sex.
Synapse has enriched 10 related papers. Consider them for comparative context: